434 related articles for article (PubMed ID: 18991959)
1. Abuse of amphetamines and structural abnormalities in the brain.
Berman S; O'Neill J; Fears S; Bartzokis G; London ED
Ann N Y Acad Sci; 2008 Oct; 1141():195-220. PubMed ID: 18991959
[TBL] [Abstract][Full Text] [Related]
2. Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry.
Daumann J; Koester P; Becker B; Wagner D; Imperati D; Gouzoulis-Mayfrank E; Tittgemeyer M
Neuroimage; 2011 Jan; 54(2):794-801. PubMed ID: 20817105
[TBL] [Abstract][Full Text] [Related]
3. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.
Chang L; Alicata D; Ernst T; Volkow N
Addiction; 2007 Apr; 102 Suppl 1():16-32. PubMed ID: 17493050
[TBL] [Abstract][Full Text] [Related]
4. Structural abnormalities in the brains of human subjects who use methamphetamine.
Thompson PM; Hayashi KM; Simon SL; Geaga JA; Hong MS; Sui Y; Lee JY; Toga AW; Ling W; London ED
J Neurosci; 2004 Jun; 24(26):6028-36. PubMed ID: 15229250
[TBL] [Abstract][Full Text] [Related]
5. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Steinkellner T; Freissmuth M; Sitte HH; Montgomery T
Biol Chem; 2011 Jan; 392(1-2):103-15. PubMed ID: 21194370
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine toxicities: classical and emerging mechanisms.
Yamamoto BK; Moszczynska A; Gudelsky GA
Ann N Y Acad Sci; 2010 Feb; 1187():101-21. PubMed ID: 20201848
[TBL] [Abstract][Full Text] [Related]
7. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.
Dalley JW; Lääne K; Theobald DE; Peña Y; Bruce CC; Huszar AC; Wojcieszek M; Everitt BJ; Robbins TW
Neuropsychopharmacology; 2007 May; 32(5):1195-206. PubMed ID: 17035931
[TBL] [Abstract][Full Text] [Related]
8. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
[TBL] [Abstract][Full Text] [Related]
9. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
10. Teratogen update: Amphetamines.
Garey JD; Lusskin SI; Scialli AR
Birth Defects Res; 2020 Sep; 112(15):1171-1182. PubMed ID: 32755038
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.
Cadet JL; Krasnova IN; Jayanthi S; Lyles J
Neurotox Res; 2007 Apr; 11(3-4):183-202. PubMed ID: 17449459
[TBL] [Abstract][Full Text] [Related]
12. Sources of variation in the design of preclinical studies assessing the effects of amphetamine-type stimulants in pregnancy and lactation.
McDonnell-Dowling K; Kelly JP
Behav Brain Res; 2015 Feb; 279():87-99. PubMed ID: 25449844
[TBL] [Abstract][Full Text] [Related]
13. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
National Toxicology Program
NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
[TBL] [Abstract][Full Text] [Related]
14. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.
Lawyer G; Bjerkan PS; Hammarberg A; Jayaram-Lindström N; Franck J; Agartz I
BMC Pharmacol; 2010 May; 10():5. PubMed ID: 20487539
[TBL] [Abstract][Full Text] [Related]
16. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine.
Morales AM; Lee B; Hellemann G; O'Neill J; London ED
Drug Alcohol Depend; 2012 Oct; 125(3):230-8. PubMed ID: 22445480
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'.
Itzhak Y; Achat-Mendes C
IUBMB Life; 2004 May; 56(5):249-55. PubMed ID: 15370888
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.
Gouzoulis-Mayfrank E; Daumann J
Dialogues Clin Neurosci; 2009; 11(3):305-17. PubMed ID: 19877498
[TBL] [Abstract][Full Text] [Related]
19. Combination effects of amphetamines under hyperthermia - the role played by oxidative stress.
da Silva DD; Silva E; Carmo H
J Appl Toxicol; 2014 Jun; 34(6):637-50. PubMed ID: 23765447
[TBL] [Abstract][Full Text] [Related]
20. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
